| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |